Samuel Salot

495 total citations
8 papers, 427 citations indexed

About

Samuel Salot is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Samuel Salot has authored 8 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Samuel Salot's work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (4 papers). Samuel Salot is often cited by papers focused on CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (4 papers). Samuel Salot collaborates with scholars based in France and United States. Samuel Salot's co-authors include Soraya Saïagh, Jérôme Tiollier, Eve Marie Neidhardt, Irène Philip, Jaafar Bennouna, Frédéric Rolland, Sylvie Négrier, Emmanuelle Bompas, Marie Audrain and Marie Rimbert and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Samuel Salot

7 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Salot France 5 400 244 24 18 15 8 427
Erev E. Tubb United States 4 442 1.1× 278 1.1× 72 3.0× 18 1.0× 28 1.9× 5 506
Carmine Menna United States 4 284 0.7× 247 1.0× 37 1.5× 7 0.4× 7 0.5× 8 335
Sami Chu United States 5 276 0.7× 182 0.7× 40 1.7× 8 0.4× 12 0.8× 6 333
Fabien Chanuc France 3 229 0.6× 185 0.8× 16 0.7× 9 0.5× 18 1.2× 5 250
Caroline Sola France 5 285 0.7× 221 0.9× 20 0.8× 10 0.6× 20 1.3× 12 314
María Angustias Parejo Fernández Spain 7 295 0.7× 138 0.6× 60 2.5× 11 0.6× 17 1.1× 25 360
Akiteru Tokunaga Japan 3 247 0.6× 249 1.0× 15 0.6× 35 1.9× 11 0.7× 6 308
Jorge Scutti United States 4 244 0.6× 272 1.1× 44 1.8× 8 0.4× 16 1.1× 4 328
Theo Nicholaou Australia 5 357 0.9× 259 1.1× 107 4.5× 19 1.1× 23 1.5× 6 431
Ignacio Casas-Avilés Spain 4 205 0.5× 146 0.6× 39 1.6× 6 0.3× 10 0.7× 4 254

Countries citing papers authored by Samuel Salot

Since Specialization
Citations

This map shows the geographic impact of Samuel Salot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Salot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Salot more than expected).

Fields of papers citing papers by Samuel Salot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Salot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Salot. The network helps show where Samuel Salot may publish in the future.

Co-authorship network of co-authors of Samuel Salot

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Salot. A scholar is included among the top collaborators of Samuel Salot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Salot. Samuel Salot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ratelade, Julien, Delphine Behr‐Roussel, Alberto L. Epstein, et al.. (2023). INTRAVESICAL ADMINISTRATION OF EG110A, A NOVEL NON-REPLICATIVE HERPES SIMPLEX VIRUS TYPE 1 (HSV1)-DERIVED VECTOR EXPRESSING THE LIGHT CHAIN OF BOTULINUM TOXIN F, INHIBITS C-TYPE FIBERS IN AN ACUTE INTRAVESICAL CAPSAICIN RAT MODEL. SHILAP Revista de lepidopterología. 7. 100817–100817. 1 indexed citations
2.
Thedrez, Aurélie, et al.. (2009). IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy. The Journal of Immunology. 182(6). 3423–3431. 58 indexed citations
3.
Toutirais, Olivier, Florian Cabillic, Gaëlle Le Friec, et al.. (2009). DNAX accessory molecule‐1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells. European Journal of Immunology. 39(5). 1361–1368. 107 indexed citations
4.
Salot, Samuel, Sylvain Bercegeay, Brigitte Dréno, et al.. (2009). Large scale expansion of Vγ9Vδ2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS “TCR γ/δ + T cell isolation kit”. Journal of Immunological Methods. 347(1-2). 12–18. 14 indexed citations
5.
Bennouna, Jaafar, Emmanuelle Bompas, Eve Marie Neidhardt, et al.. (2008). Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. Cancer Immunology Immunotherapy. 57(11). 1599–1609. 208 indexed citations
6.
Salot, Samuel, Catherine Laplace, Soraya Saïagh, et al.. (2007). Large scale expansion of γ9δ2 T lymphocytes: Innacell γδ™ cell therapy product. Journal of Immunological Methods. 326(1-2). 63–75. 35 indexed citations
7.
Squiban, Patrick, Emmanuelle Bompas, Jaafar Bennouna, et al.. (2007). V{gamma}9V{delta}2 T ({gamma}{delta}) lymphocytes: a promising approach for immunotherapy of solid tumors. 25. 3064.
8.
Bompas, Emmanuelle, Eve Marie Neidhardt, Frédéric Rolland, et al.. (2006). An autologous Vγ9Vδ2 T lymphocytes cell therapy product generated by BrHPP (INNACELL Gamma Delta [IGD]) in metastatic renal cell carcinoma patients: Phase I clinical trial results. Journal of Clinical Oncology. 24(18_suppl). 2550–2550. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erev E. Tubb Breakdown of academic impact, for papers by Carmine Menna Breakdown of academic impact, for papers by Sami Chu Breakdown of academic impact, for papers by Fabien Chanuc Breakdown of academic impact, for papers by Caroline Sola Breakdown of academic impact, for papers by María Angustias Parejo Fernández Breakdown of academic impact, for papers by Akiteru Tokunaga Breakdown of academic impact, for papers by Jorge Scutti Breakdown of academic impact, for papers by Theo Nicholaou Breakdown of academic impact, for papers by Ignacio Casas-Avilés
Rankless by CCL
2026